Mortality analysis of COVID-19 infection in chronic kidney disease, haemodialysis and renal transplant patients compared with patients without kidney disease: a nationwide analysis from Turkey.


Ozturk S., Turgutalp K., Arici M., Odabas A. R. , Altiparmak M. R. , Aydin Z., ...More

Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association, vol.35, pp.2083-2095, 2020 (Journal Indexed in SCI) identifier identifier identifier

  • Publication Type: Article / Article
  • Volume: 35
  • Publication Date: 2020
  • Doi Number: 10.1093/ndt/gfaa271
  • Title of Journal : Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association
  • Page Numbers: pp.2083-2095
  • Keywords: COVID-19, haemodialysis, kidney disease, mortality, renal transplantation, REPLACEMENT, POPULATION, OUTCOMES, RISK

Abstract

Background. Chronic kidney disease (CKD) and immunosuppression, such as in renal transplantation (RT), stand as one of the established potential risk factors for severe coronavirus disease 2019 (COVID-19). Case morbidity and mortality rates for any type of infection have always been much higher in CKD, haemodialysis (HD) and RT patients than in the general population. A large study comparing COVID-19 outcome in moderate to advanced CKD (Stages 3-5), HD and RT patients with a control group of patients is still lacking.